| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/06/2004 | US6717030 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 04/06/2004 | US6717017 4'-alkyl,6'-(protected hydroxy),7'-hydroxy-spiro(cyclopropane-1,5'-hexahydroindan-2,3 a(4),7a(1)-triene) compound of given formula, intermediate to illudin analogs of the mushroom omphalotus illudens |
| 04/06/2004 | US6717015 Venlafaxine besylate |
| 04/06/2004 | US6717012 Such as alpha-phenyl-n-(7-tert-butoxycarbonylamino-3,5-dimethyladamantane)nitrone for treatment of neurological/ inflammatory diorders, and aging, which result from the overproduction of nitric oxide |
| 04/06/2004 | US6717008 Use as anorectics, treating obesity and type ii diabetes; c2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group |
| 04/06/2004 | US6717000 Antidepressants |
| 04/06/2004 | US6716987 Phosphodiesterase iv inhibitors |
| 04/06/2004 | US6716986 Metabolites of the 5ht2a antagonist (+)- alpha -(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol, preparation and intermediates |
| 04/06/2004 | US6716985 Alcoholism, psychological disorders |
| 04/06/2004 | US6716983 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
| 04/06/2004 | US6716981 Process for the preparation of N-(amino-4, 6-dihalo-pyrimidine) formamides |
| 04/06/2004 | US6716978 For therapy and prohylaxis of inflammatory diseases including joint inflammation, crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (copd) including asthma, chronic bronchitis |
| 04/06/2004 | US6716884 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof |
| 04/06/2004 | US6716883 Especially induced by smoking; administering an aryl hydrocarbon receptor antagonist, resveratrol |
| 04/06/2004 | US6716880 Function as sulfatase and/or blocking estrogen receptors; prophylaxis and therapy |
| 04/06/2004 | US6716879 Administering an effective amount of sulfonylamino-substituted n-aryl- or heteroacryl or alkyl or cycloalkylcarboxamide derivatives or salts, esters, amides or prodrug to treat tumor |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716877 Method to treat chronic heart failure and/or elevated cholesterol levels |
| 04/06/2004 | US6716876 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 04/06/2004 | US6716875 With angiotensin ii antagonist (losartan); angiotensin i converting enzyme inhibitor (captopril); hypotensive agent and for congestive heart failure; renin inhibitor is peptide |
| 04/06/2004 | US6716872 Using the compounds for treating pain, anxiety and various other diseases or conditions. |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716869 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide |
| 04/06/2004 | US6716868 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 04/06/2004 | US6716867 Use of dexmedetomidine for ICU sedation |
| 04/06/2004 | US6716865 Benzoxa- and benzthiazoles |
| 04/06/2004 | US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 04/06/2004 | US6716860 Azo amino acids derivatives |
| 04/06/2004 | US6716859 Anticancer agents |
| 04/06/2004 | US6716858 Derivatives of vitamin b6 and vitamin b1, preferred being pyridoxamine and thiamine pyrophosphate; inhibitors of post-amadori advanced glycation end products, late maillard products; oxidative stress |
| 04/06/2004 | US6716857 1-(3-hydrocarbyloxyimino-3-(1-alkyl-1,2,5,6-tetrahydropyrid-3-yl) -alkylpyrrolidin-2-one derivatives; receptivity; analgesics, glaucoma, psychosis, schizophrenia, anxiolytic agents, bipolar disorders; antidepressants; sleep disorders |
| 04/06/2004 | US6716856 Cell proliferative disorders or alzheimer's disease; reduced toxicity; cdk/cyclin kinase inhibitory activity |
| 04/06/2004 | US6716855 Antithrombotic amides |
| 04/06/2004 | US6716854 Treatments for restless legs syndrome |
| 04/06/2004 | US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
| 04/06/2004 | US6716851 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716849 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716846 High affinity ligands for nociceptin receptor ORL-1 |
| 04/06/2004 | US6716845 Barbituric acid derivatives |
| 04/06/2004 | US6716843 Inhibitor of dipeptidyl-peptidase iv |
| 04/06/2004 | US6716842 Non-insulin dependent diabetes mellitus, obesity, hyperglycemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia in a mammal |
| 04/06/2004 | US6716841 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 04/06/2004 | US6716840 Agonists of the melanocortin-4 receptor (?mc-4r?); useful treating obesity and type 2 diabetes |
| 04/06/2004 | US6716839 Inhibitor of factor xa |
| 04/06/2004 | US6716837 Heterocyclic compounds for the treatment of migraine |
| 04/06/2004 | US6716836 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716835 Use of diltiazem for treating retinal pathologies |
| 04/06/2004 | US6716834 Thiochromane derivatives and their use as thrombin inhibitors |
| 04/06/2004 | US6716833 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 04/06/2004 | US6716831 2,4-diamino-pyrimidine deprivatives having anti-cell proliferative activity |
| 04/06/2004 | US6716830 For therapy and prophylaxis of ophthalmic, otic or nasal infections and attendant inflammation |
| 04/06/2004 | US6716829 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716825 Osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like. |
| 04/06/2004 | US6716824 Antitumor |
| 04/06/2004 | US6716822 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition |
| 04/06/2004 | US6716821 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| 04/06/2004 | US6716819 Exposing infectious microbial cells to endogenous antimicrobials in bodily fluids by contacting body surfaces which secrete these bodily fluids with an effective amount of non-ionic osmolytes with low transepithelial permeability |
| 04/06/2004 | US6716815 Comprises whey/soy protein, casein-polypeptide, fatty acid, and insoluble vegetable/fruit fiber which stimulates cholecystokinin levels for better regulation of glucose and insulin levels following meal consumption; diabetes |
| 04/06/2004 | US6716632 System for stabilizing samples |
| 04/06/2004 | US6716628 Chondrogenesis promoters and indolin-2-one derivatives |
| 04/06/2004 | US6716605 Indole derivatives having an antiviral activity |
| 04/06/2004 | US6716603 Nucleic acids encoding a chloride channel protein |
| 04/06/2004 | US6716592 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716585 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis |
| 04/06/2004 | US6716583 Methods of producing nucleic acid ligands |
| 04/06/2004 | US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| 04/06/2004 | US6716459 Using plant extract; corosolic acid |
| 04/06/2004 | US6716450 Nanocapsule having core-shell structure, consisting essentially of randomly branched hydrophilic polymer having hydrophobic chain-end moieties, and bioactive molecule encapsulated within nanocapsule |
| 04/06/2004 | US6716449 Dosage form; antagonist to attenuate a side effect of said opioid agonist; analgesia for at least about eight hours when administered to human patients |
| 04/06/2004 | US6716447 Stable carotene xanthophyll beadlet compositions and methods of use |
| 04/06/2004 | US6716446 Medicament against dysmenorrhoea and premenstrual syndrome |
| 04/06/2004 | US6716442 Cyclic applying of pesticides |
| 04/06/2004 | US6716441 Article comprising dispensing means with applied release composition including selected skin care active, release agent and barrier protectant; oleaginous, partially transferable to wearer's skin; contains ethoxylated c20-c40 fatty alcohol |
| 04/06/2004 | US6716436 In combination with cosmetically acceptable excipient at least one nitric oxide precursor compound which is l-arginine analogue or one of its derivatives or salts |
| 04/06/2004 | US6716424 Streptococcus and isoflavone-containing composition |
| 04/06/2004 | US6716418 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 04/06/2004 | US6716417 Condensation of heated vapor to form aerosol particles |
| 04/06/2004 | US6716416 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |
| 04/06/2004 | US6716415 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of a sedative-hypnotic, such as zaleplon, zolpidem or zopiclone. |
| 04/06/2004 | US6716414 Aerosol solution for use in an aerosol inhaler |
| 04/06/2004 | US6716411 Method for finding nucleotide synthesis inhibitors having fewer side effects |
| 04/06/2004 | CA2359061C Crystal polymorphism of aminoethylphenoxyacetic acid derivative |
| 04/06/2004 | CA2306005C Gel preparation containing polystyrene-sulfonates |
| 04/06/2004 | CA2299399C Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
| 04/06/2004 | CA2293672C Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors |
| 04/06/2004 | CA2171294C Viscous surfactant emulsion compositions |
| 04/06/2004 | CA2129430C N, n'-substituted imidocarbonimidic diamides derived from hydroxylamines |
| 04/06/2004 | CA2129235C Inhibition of respiratory burst using posttranslational modification inhibitors |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/06/2004 | CA2121060C Preparation of lignan analogues |
| 04/06/2004 | CA2104515C Composition for accelerating healing of wound |
| 04/06/2004 | CA2104114C Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
| 04/06/2004 | CA2089563C Oligonucleotide modulation of cell adhesion |
| 04/06/2004 | CA2087286C Thioether conjugates |
| 04/06/2004 | CA2084222C Novel trans cyclopentanyl purine analogs useful as immunosuppressants |